Literature DB >> 3653718

Improvement in efficacy of corticosteroid therapy in an animal model of proliferative vitreoretinopathy by pretreatment.

D B Chandler1, T Hida, S Sheta, A D Proia, R Machemer.   

Abstract

Intraocular injection of the corticosteroid triamcinolone acetonide reduces the incidence of retinal detachment in rabbit eyes injected with tissue-cultured fibroblasts. When the steroid was injected simultaneously with the cells, a reduction of retinal detachment from 93% (control) to 75% (treated) was achieved on day 28. When the steroid was injected 24 h preceding cell injection, the reduction of retinal detachment was from 85% (control) to 43% (treated). The development of retinal detachment is caused by proliferation of injected fibroblasts. Reduction of this proliferation is probably achieved partially through direct inhibition of mitosis, but more important may be the reduction of the reactive inflammatory process.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3653718     DOI: 10.1007/BF02150144

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  25 in total

1.  EFFECT OF STEROIDS ON GROWTH OF MOUSE FIBROBLASTS IN VITRO.

Authors:  A G RUHMANN; D L BERLINER
Journal:  Endocrinology       Date:  1965-05       Impact factor: 4.736

2.  Multiple control of inflammation by glucocorticoids.

Authors:  M Di Rosa; A Calignano; R Carnuccio; A Ialenti; L Sautebin
Journal:  Agents Actions       Date:  1986-01

Review 3.  The antinflammatory effects of glucocorticosteroids. A brief review of the literature.

Authors:  A M Dannenberg
Journal:  Inflammation       Date:  1979-07       Impact factor: 4.092

4.  The effect of triamcinolone acetonide on a refined experimental model of proliferative vitreoretinopathy.

Authors:  D B Chandler; G Rozakis; E de Juan; R Machemer
Journal:  Am J Ophthalmol       Date:  1985-06-15       Impact factor: 5.258

5.  Control of experimental massive periretinal proliferation by daunomycin: dose-response relation.

Authors:  P Wiedemann; M Kirmani; M Santana; N Sorgente; S J Ryan
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1983       Impact factor: 3.117

6.  Pigment epithelium proliferation in retinal detachment (massive periretinal proliferation).

Authors:  R Machemer; H Laqua
Journal:  Am J Ophthalmol       Date:  1975-07       Impact factor: 5.258

7.  Glucocorticosteroids I: anti-inflammatory mechanisms.

Authors:  H N Claman
Journal:  Hosp Pract (Off Ed)       Date:  1983-07

8.  The role of cellular proliferation in an experimental model of massive periretinal proliferation.

Authors:  D M Fastenberg; K R Diddie; K Dorey; S J Ryan
Journal:  Am J Ophthalmol       Date:  1982-05       Impact factor: 5.258

9.  Surgical treatments of proliferative vitreoretinopathy.

Authors:  A E Jalkh; M P Avila; C L Schepens; C Azzolini; J E Duncan; C L Trempe
Journal:  Arch Ophthalmol       Date:  1984-08

10.  Fluorouracil for the treatment of massive periretinal proliferation.

Authors:  M S Blumenkranz; A Ophir; A J Claflin; A Hajek
Journal:  Am J Ophthalmol       Date:  1982-10       Impact factor: 5.258

View more
  14 in total

1.  Evaluation of radiation therapy for experimental proliferative vitreoretinopathy in rabbits.

Authors:  S Kuriyama; T Ohuchi; N Yoshimura; Y Honda; M Hiraoka; M Abe
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1990       Impact factor: 3.117

2.  Evaluation of a single intravitreal injection of dexamethasone phosphate in vitrectomy surgery for diabetic retinopathy complications.

Authors:  G W Blankenship
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1991       Impact factor: 3.117

3.  Systemic corticosteroids reduce the risk of cellophane membranes after retinal detachment surgery: a prospective randomized placebo-controlled double-blind clinical trial.

Authors:  Fritz Koerner; Ursula Koerner-Stiefbold; Justus G Garweg
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-01-21       Impact factor: 3.117

4.  The lack of an effect of intraocular steroids on irradiated fibroblasts in experimental proliferative vitreoretinopathy.

Authors:  D B Chandler; T Hida; G Rozakis; V S Forbes; R Machemer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1992       Impact factor: 3.117

5.  Histopathological and ophthalmoscopic evaluation of apocynin on experimental proliferative vitreoretinopathy in rabbit eyes.

Authors:  Murat Atabey Ozer; Nihat Polat; Serkan Ozen; Tevfik Ogurel; Hakan Parlakpinar; Nigar Vardi
Journal:  Int Ophthalmol       Date:  2016-08-05       Impact factor: 2.031

Review 6.  Proliferative vitreoretinopathy: pathobiology, surgical management, and adjunctive treatment.

Authors:  D G Charteris
Journal:  Br J Ophthalmol       Date:  1995-10       Impact factor: 4.638

Review 7.  Proliferative vitreoretinopathy.

Authors:  P K Leaver
Journal:  Br J Ophthalmol       Date:  1995-10       Impact factor: 4.638

8.  The effect of a preoperative subconjuntival injection of dexamethasone on blood-retinal barrier breakdown following scleral buckling retinal detachment surgery: a prospective randomized placebo-controlled double blind clinical trial.

Authors:  Ernesto Bali; Eric J Feron; Ed Peperkamp; Marc Veckeneer; Paul G Mulder; Jan C van Meurs
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-02-25       Impact factor: 3.117

9.  Daunorubicin treatment in a refined experimental model of proliferative vitreoretinopathy.

Authors:  J A Khawly; P Saloupis; D L Hatchell; R Machemer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1991       Impact factor: 3.117

10.  Corticosteroids and daunomycin in the prevention of experimental proliferative vitreoretinopathy induced by macrophages.

Authors:  Y N Hui; H C Liang; Y S Cai; B Kirchhof; K Heimann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1993-02       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.